These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 33282736)

  • 1. Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.
    Bewarder M; Kiefer M; Moelle C; Goerens L; Stilgenbauer S; Christofyllakis K; Kaddu-Mulindwa D; Fadle N; Regitz E; Neumann F; Hoth M; Preuss KD; Pfreundschuh M; Thurner L
    Front Oncol; 2020; 10():580364. PubMed ID: 33282736
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hyper-
    Thurner L; Preuss KD; Bewarder M; Kemele M; Fadle N; Regitz E; Altmeyer S; Schormann C; Poeschel V; Ziepert M; Walter S; Roth P; Weller M; Szczepanowski M; Klapper W; Monoranu C; Rosenwald A; Möller P; Hartmann S; Hansmann ML; Mackensen A; Schäfer H; Schorb E; Illerhaus G; Buslei R; Bohle RM; Stilgenbauer S; Kim YJ; Pfreundschuh M
    Blood; 2018 Dec; 132(26):2744-2753. PubMed ID: 30249786
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Ars2-containing bispecific, Fab- and IgG1-format BAR-bodies to target DLBCL cells.
    Kiefer M; Thurner L; Bock T; Cetin O; Kos I; Lesan V; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Hoth M; Neumann F; Preuss KD; Pfreundschuh M; Christofyllakis K; Bewarder M
    EJHaem; 2023 Feb; 4(1):125-134. PubMed ID: 36819155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hyper-N-glycosylated SEL1L3 as auto-antigenic B-cell receptor target of primary vitreoretinal lymphomas.
    Elbert M; Neumann F; Kiefer M; Christofyllakis K; Balensiefer B; Kos I; Carbon G; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Fend F; Bonzheim I; Thurner L; Bewarder M
    Sci Rep; 2024 Apr; 14(1):9571. PubMed ID: 38671086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Specific B-Cell Receptor Antigens in Lymphomagenesis.
    Thurner L; Hartmann S; Neumann F; Hoth M; Stilgenbauer S; Küppers R; Preuss KD; Bewarder M
    Front Oncol; 2020; 10():604685. PubMed ID: 33363034
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary central nervous system lymphoma in Korea: comparison of B- and T-cell lymphomas.
    Choi JS; Nam DH; Ko YH; Seo JW; Choi YL; Suh YL; Ree HJ
    Am J Surg Pathol; 2003 Jul; 27(7):919-28. PubMed ID: 12826884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The B-cell Receptor Autoantigen LRPAP1 Can Replace Variable Antibody Regions to Target Mantle Cell Lymphoma Cells.
    Bewarder M; Kiefer M; Will H; Olesch K; Moelle C; Stilgenbauer S; Christofyllakis K; Kaddu-Mulindwa D; Bittenbring JT; Fadle N; Regitz E; Kaschek L; Hoth M; Neumann F; Preuss KD; Pfreundschuh M; Thurner L
    Hemasphere; 2021 Aug; 5(8):e620. PubMed ID: 34263144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of immunoglobulin transcription factors in primary intraocular lymphoma and primary central nervous system lymphoma.
    Coupland SE; Loddenkemper C; Smith JR; Braziel RM; Charlotte F; Anagnostopoulos I; Stein H
    Invest Ophthalmol Vis Sci; 2005 Nov; 46(11):3957-64. PubMed ID: 16249468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Survival of human lymphoma cells requires B-cell receptor engagement by self-antigens.
    Young RM; Wu T; Schmitz R; Dawood M; Xiao W; Phelan JD; Xu W; Menard L; Meffre E; Chan WC; Jaffe ES; Gascoyne RD; Campo E; Rosenwald A; Ott G; Delabie J; Rimsza LM; Staudt LM
    Proc Natl Acad Sci U S A; 2015 Nov; 112(44):13447-54. PubMed ID: 26483459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Similar chemokine receptor profiles in lymphomas with central nervous system involvement - possible biomarkers for patient selection for central nervous system prophylaxis, a retrospective study.
    Lemma SA; Pasanen AK; Haapasaari KM; Sippola A; Sormunen R; Soini Y; Jantunen E; Koivunen P; Salokorpi N; Bloigu R; Turpeenniemi-Hujanen T; Kuittinen O
    Eur J Haematol; 2016 May; 96(5):492-501. PubMed ID: 26153511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Primary central nervous system diffuse large B-cell lymphoma has poorer immune cell infiltration and prognosis than its peripheral counterpart.
    Chang C; Lin CH; Cheng AL; Medeiros LJ; Chang KC
    Histopathology; 2015 Nov; 67(5):625-35. PubMed ID: 25829022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preferential up-regulation of osteopontin in primary central nervous system lymphoma does not correlate with putative receptor CD44v6 or CD44H expression.
    Yuan J; Gu K; He J; Sharma S
    Hum Pathol; 2013 Apr; 44(4):606-11. PubMed ID: 23089492
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Array-based profiling of the lymphoma cell DNA methylome does not unequivocally distinguish primary lymphomas of the central nervous system from non-CNS diffuse large B-cell lymphomas.
    Vogt J; Wagener R; Montesinos-Rongen M; Ammerpohl O; Paulus W; Deckert M; Siebert R
    Genes Chromosomes Cancer; 2019 Jan; 58(1):66-69. PubMed ID: 30284345
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recombinant thyroid peroxidase-specific Fab converted to immunoglobulin G (IgG) molecules: evidence for thyroid cell damage by IgG1, but not IgG4, autoantibodies.
    Guo J; Jaume JC; Rapoport B; McLachlan SM
    J Clin Endocrinol Metab; 1997 Mar; 82(3):925-31. PubMed ID: 9062508
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The process of somatic hypermutation increases polyreactivity for central nervous system antigens in primary central nervous system lymphoma.
    Montesinos-Rongen M; Terrao M; May C; Marcus K; Blümcke I; Hellmich M; Küppers R; Brunn A; Deckert M
    Haematologica; 2021 Mar; 106(3):708-717. PubMed ID: 32193251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted cell uptake of a noninternalizing antibody through conjugation to iron oxide nanoparticles in primary central nervous system lymphoma.
    Wang T; Kievit FM; Veiseh O; Arami H; Stephen ZR; Fang C; Liu Y; Ellenbogen RG; Zhang M
    World Neurosurg; 2013; 80(1-2):134-41. PubMed ID: 23298674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Primary Central Nervous System (CNS) Lymphoma B Cell Receptors Recognize CNS Proteins.
    Montesinos-Rongen M; Purschke FG; Brunn A; May C; Nordhoff E; Marcus K; Deckert M
    J Immunol; 2015 Aug; 195(3):1312-9. PubMed ID: 26116512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential expression of Toll-like receptor (TLR) and B cell receptor (BCR) signaling molecules in primary diffuse large B-cell lymphoma of the central nervous system.
    Akhter A; Masir N; Elyamany G; Phang KC; Mahe E; Al-Zahrani AM; Shabani-Rad MT; Stewart DA; Mansoor A
    J Neurooncol; 2015 Jan; 121(2):289-96. PubMed ID: 25391967
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systems biology of primary CNS lymphoma: from genetic aberrations to modeling in mice.
    Deckert M; Montesinos-Rongen M; Brunn A; Siebert R
    Acta Neuropathol; 2014 Feb; 127(2):175-88. PubMed ID: 24240734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma.
    Dunleavy K; Erdmann T; Lenz G
    Cancer Treat Rev; 2018 Apr; 65():41-46. PubMed ID: 29549872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.